BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Etherna And Almirall Advance LAD116 mRNA LNP Therapy Into IND Enabling Studies For Non Melanoma Skin Cancer

etherna, a leading provider of cutting-edge mRNA and lipid nanoparticle (LNP) technology across the biotech and pharma industry, announces that one o...

February 25, 2026 | News

Hansa Biopharma Announces FDA Acceptance of Imlifidase Biologics License Application

Hansa Biopharma AB, ("Hansa" or "the Company"), announced that its Biologics License Application (BLA) for imlifidase has been accepted by the U.S. F...

February 24, 2026 | News

Takeda Reports Positive Phase 3 KEPLER Data For ENTYVIO In Pediatric Ulcerative Colitis

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either conven...

February 23, 2026 | News

ImmunityBio Partners With Accord Healthcare To Expand ANKTIVA Access Across Europe

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, announced a partnership with Accord Healthcare to provide access to ANKTI...

February 23, 2026 | News

ANKTIVA Plus BCG Secures European Commission Authorization As First Immunotherapy For BCG Unresponsive NMIBC

ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for non-muscle invasive blad...

February 20, 2026 | News

Mammotome Introduces In Room MRI Guided Breast Biopsy System To Improve Clinical Workflow

Mammotome, a Danaher company, announces the Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System, the industry's first system designed t...

February 19, 2026 | News

Beactica Therapeutics AB Secures EUR 2.5 Million EIC Grant To Advance Precision Immune Therapy For Glioblastoma

Beactica Therapeutics AB, a Swedish precision medicine company, announced that it, together with leading glioblastoma researchers at KU Leuven, has been aw...

February 18, 2026 | News

Bio Techne Corporation Announces CE IVD Marking For Ella Benchtop Immunoassay Platform In European Union

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform tha...

February 18, 2026 | News

European Commission Approves Gotenfia® Biosimilar, Expanding Golimumab Access Across Europe

European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed b...

February 17, 2026 | News

Ribo And Ribocure Sign Global Licensing Deal With Madrigal For Six siRNA Programmes In MASH

Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") announced that they have entere...

February 13, 2026 | News

Berlin Heals Secures Over USD 10 Million To Advance Cardiac Microcurrent Therapy For Heart Failure

Berlin Heals Holding AG, a MedTech company focused on transformative therapies for heart failure, announced the successful closing of a new financing ...

February 13, 2026 | News

IFPA And WHO Foundation Launch Multi Year Alliance To Advance Global Psoriasis Care

The International Federation of Psoriasis Associations (IFPA) and the WHO Foundation have signed a multi-year collaboration agreement supporting WHO effort...

February 12, 2026 | News

SOPHiA GENETICS Expands US Footprint With Two Major Health System Partnerships

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, announced the addition of two of the largest U.S. healthcare systems ...

February 12, 2026 | News

Eurofins Viracor BioPharma Expands GLP And GCP Bioanalytical Testing Capabilities

Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers...

February 11, 2026 | News

Stay Connected